QGENMID

Qiagen N.V.

HealthcareMedical - Diagnostics & Research
$39.41
$0.00(+1.21%)
52W$32.53
$57.82
Updated Jun 29, 02:00 AM
RSI63
RS Rating34/99
Beta0.30
Volatility32%
F-Score8/9
Mkt Cap$8.1B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Qiagen N.V. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 34), showing significant lag compared to the market leaders. Earnings contraction of 20% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
34
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.30
vs S&P 500
LOW VOL
52W Position
27%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$36.26
50 SMA > 100 SMA$40.47
100 SMA > 150 SMA$43.23
150 SMA > 200 SMA$43.94

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$37.15+6.09%ABOVE
50 SMA$36.26+8.69%ABOVE
100 SMA$40.47-2.62%BELOW
150 SMA$43.23-8.85%BELOW
200 SMA$43.94-10.31%BELOW

Price Performance

1D+1.2%
1W+8.6%
1M+10.9%
3M-0.8%
6M-13.1%
YTD-12.8%
1Y-18.0%
3Y-6.3%
52-Week Trading Range27% from low
$39.41
52W Low$32.53
52W High$57.82

Technical Indicators

RSI (14)BULLISH
62.8
305070
Setup ScoreCOOL
6/10
Base depth: 24.9%

Risk Profile

Beta
0.30
52W Vol
32%
ATR
$0.99
Max DD (1Y)
-41%

Volume Analysis

Today
862.9K
50D Avg
2.17M
Vol Ratio
0.40x
Liquidity
LIQUID

Earnings Momentum

Q2'25+153%
$0.44
Q3'25+36%
$0.60
Q4'25+27%
$0.52
Q1'26-20%
$0.33
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+5.02%
5 Years:+2.25%
3 Years:-0.81%
TTM:+4.79%

Compounded Profit Growth

10 Years:+13.80%
5 Years:+44.84%
3 Years:-0.16%
TTM:+339.53%

Stock Price CAGR

10 Years:+5.89%
5 Years:-5.51%
3 Years:-6.32%
1 Year:-17.96%

Return on Equity

10Y Avg:7.7%
5Y Avg:10.7%
3Y Avg:7.7%
Last Year:11.3%

Key Metrics

Market Cap$8.1B
Gross Margin61.8%
Net Margin20.3%
Piotroski F-Score8/9

Frequently Asked Questions

Is QGEN in an uptrend right now?

QGEN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is QGEN overbought or oversold?

QGEN's RSI (14) is 63. The stock is in neutral territory, neither overbought nor oversold.

Is QGEN outperforming the market?

QGEN has a Relative Strength (RS) Rating of 34 out of 99. QGEN is currently lagging the broader market.

Where is QGEN in its 52-week range?

QGEN is trading at $39.41, which is 68% of its 52-week high ($57.82) and 27% above its 52-week low ($32.53).

How volatile is QGEN?

QGEN has a Beta of 0.30 and 52-week volatility of 32%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.